Aloglutamol is an antacid, an aluminium compound.[1] It is a salt of aluminium, gluconic acid, and tris.[2][3] It is usually given orally in doses of 0.5 to 1 g.[4] Proprietary names include Altris, Pyreses, Tasto and Sabro.[4][5]

Aloglutamol
Aloglutamol.png
Clinical data
Other namesTasto; trometamolgluconate aluminum
ATC code
Identifiers
  • Dihydroxyaluminum gluconate; Tris(hydroxymethyl)aminomethane (1:1)
CAS Number
ChemSpider
UNII
Chemical and physical data
FormulaC10H24NO12
Molar mass377.28 g·mol−1
3D model (JSmol)
  • C([C@H]([C@H]([C@@H]([C@H](C(=O)O[Al](O)O)O)O)O)O)O.C(C(CO)(CO)N)O
  • InChI=1S/C6H12O7.C4H11NO3.Al.2H2O/c7-1-2(8)3(9)4(10)5(11)6(12)13;5-4(1-6,2-7)3-8;;;/h2-5,7-11H,1H2,(H,12,13);6-8H,1-3,5H2;;2*1H2/q;;+3;;/p-3/t2-,3-,4+,5-;;;;/m1..../s1 ☒N
  • Key:GJJYZOBRHIMORS-GQOAHPRESA-K ☒N
 ☒NcheckY (what is this?)  (verify)

ReferencesEdit

  1. ^ Dikshith, T. S. S. (1 November 2010). Handbook of Chemicals and Safety. Taylor & Francis US. p. 69. ISBN 978-1-4398-2060-5. Retrieved 29 April 2012.
  2. ^ Bonanno A, Tonini GM, de Marinis S (1978). "[Use of Aloglutamol in uremic patients on dialysis (author's transl]". Urol. Int. (in French). 33 (4): 213–21. doi:10.1159/000280201. PMID 705977.
  3. ^ Aloglutamol, Comparative Toxicogenomics Database
  4. ^ a b Martindale, William (1993). The Extra Pharmacopoeia. Royal Pharmaceutical Society of Great Britain, Dept. of Pharmaceutical Sciences, Pharmaceutical Press. p. 869. ISBN 978-0-85369-300-0. Retrieved 29 April 2012.
  5. ^ Negwer, Martin; Scharnow, Hans-Georg (2001). Organic-chemical drugs and their synonyms: (an international survey). Wiley-VCH. p. 157. ISBN 978-3-527-30247-5. Retrieved 29 April 2012.